Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

In the Coronavirus Vaccine Race, AIM Stock Isn’t a Likely Winner

By Vince Martin, InvestorPlace Contributor
AIM stock was a big winner on hopes it could join the response to the coronavirus. But its history suggests those hopes are too optimistic.

7 Small-Cap Stocks That Are Not Worth a Second Glance

By Louis Navellier, Editor, Growth Investor
The market may be hitting new highs, but not all small-cap stocks are doing well. The ones on this list are all stock to sell, so beware.

Neither the Time nor the Market to Buy Luckin Coffee Stock

By Vince Martin, InvestorPlace Contributor
LK stock has caught a bounce as investors tiptoe back into the market. But downside risk remains elevated.

Why Carnival Stock Will Sink Further

By Tom Taulli, InvestorPlace Contributor
Along with all other cruise lines, Carnival has undergone extreme pressure during the past month or so. And while the stock price is at rock-bottom prices, there could easily be more on the downside.

BKNG Stock Has a Lot More Downside on Industry Headwinds

By Faisal Humayun, InvestorPlace Contributor
With majority of travel bookings in the first half of the year, the company is likely to face two years of growth headwind. Strong fundamentals to navigate crisis.

Inovio Pharmaceuticals Will Fall Once Coronavirus Fears Fade

By Ian Bezek, InvestorPlace Contributor
INO stock has moved higher based on Inovio's hunt for a coronavirus vaccine. But this race also makes the pharmaceutical firm a one-dimensional investment.

Starbucks Stock Isn’t Among the Best Choices in the Current Environment

By Larry Ramer, InvestorPlace Contributor
Investors who only plan to hold SBUX stock for more than a few weeks but less than a year (when strong fears about the coronavirus are likely to be largely gone) should avoid the coffee retailer's shares.

Oil Wars and Bear Markets Are Too Much for Nio Stock

By Josh Enomoto, InvestorPlace Contributor
Even under bull market conditions, Nio stock was a risky opportunity. But in a bear market that is especially tough on automakers, Nio is too treacherous.

Why Fear is Temporarily Driving Sturm Ruger Stock to Higher Highs

By Ian Cooper, InvestorPlace Contributor
The coronavirus from China panic won’t last forever, and neither will recent higher highs in gun stocks like Ruger stock.

It’s Time for Investors to Run Far Away From iBio Stock

By Chris Tyler, InvestorPlace Contributor
Don’t let me talk you out of iBio stock, but a bit of skepticism is required given the massive hype behind this bio-pharmaceutical COVID-19 play.

It Might Be Too Early to Consider Buying Apple Stock

By Faisal Humayun, InvestorPlace Contributor
Coronavirus will impact Apple stock throughout 2020. But 5G phones and wearables will enable the company to grow next year.

The Coronavirus Is the Latest Obstacle for CGC Stock

By Chris Markoch, InvestorPlace Contributor
The cannabis industry faced significant challenges before the coronavirus erupted. But with the pandemic bringing everything to a halt, CGC stock is simply not worth the risk.

Can Restructuring Salvage CHK Stock?

By Will Ashworth, InvestorPlace Contributor
The price war between Saudi Arabia and Russia is enough to scare a giant oil firm, let alone an embattled one like Chesapeake Energy. Therefore, unless a miracle occurs, CHK stock is a sell.

iBio Stock Isn’t the Coronavirus Play Investors Want It to Be

By Todd Shriber, InvestorPlace Contributor
Underscoring the volatility associated with companies purporting to be on the cusps of cures or treatments for international pandemics, IBIO has more than quadrupled just this month, but the stock resides 63.53% below the 52-week high notched in early March.

Stop Chasing Coronavirus Plays Like Moderna Stock

By Vince Martin, InvestorPlace Contributor
Stocks like MRNA stock have soared on hopes they will benefit from the coronavirus pandemic. But history shows few, if any, actually will.

Without Boeing, General Electric Stock Is Dead in the Water

By InvestorPlace Research Staff
With the airline industry taking a cataclysmic hit, there’s simply no way that the recovery narrative for GE stock is feasible.

Virgin Galactic Stock: Where Speculation Meets the Final Frontier

By Todd Shriber, InvestorPlace Contributor
Virgin Galactic offers a lot of potential, but the stock is battered and still expensive. Interested investors should avoid it for now.

LYFT Stock Faces More Than a Bad Review from the Coronavirus

By Josh Enomoto, InvestorPlace Contributor
Ride sharing and the prominence of individual names like LYFT stock was easily among the most promising investments. Now, the underlying company is in a fight for its life.

Intel Will Survive but INTC Stock Could Fall Much Further

By Mark R. Hake, CFA
Intel will survive just fine given its massive FCF, but INTC stock could fall much further. Even though FCF covers the dividend, INTC stock could drop over 35% to its highest dividend yield.
Load More Articles